Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Development of a ketone-aware automated insulin delivery system to enable safe use of sodium-glucose cotransporter inhibitors in people with type 1 diabetes

Award Number: R01DK145849
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2026
PERIOD OF PERFORMANCE END DATE: 12/31/2029

Group Awards By:

View Award Description

Development of a ketone-aware automated insulin delivery system to enable safe use of sodium-glucose cotransporter inhibitors in people with type 1 diabetes - Project Summary Despite recent advances in diabetes treatment and technology (e.g., automated insulin delivery [AID] systems), achieving recommended glycemic targets is still difficult for people with type 1 diabetes (T1D) and, worrisomely, T1D confers substantial cardiorenal risk even when conventional glycemic targets are achieved. The sodium- glucose cotransporter inhibitors (SGLTi) are antihyperglycemic medications that have demonstrated significant cardiorenal benefits in people with and without type 2 diabetes, including reductions in kidney disease progression and hospitalization for heart failure. SGLTi medications have been tested in people with T1D and shown beneficial effects on glycemic control; however, they also contribute to an increased risk of ketoacidosis that has drastically limited their clinical utility in this population. AID systems pair continuous glucose monitors (CGM) and insulin pumps with control algorithms that automatically modulate insulin delivery in real-time. Continuous ketone monitoring (CKM) is a rapidly evolving technology with the potential to prevent ketoacidosis by tracking ketone levels, transmitting results to a dedicated smartphone or device, and providing early warnings of ketone elevations. A combined CKM/CGM biowearable sensor (Abbott Diabetes Care; Alameda, CA) is currently in clinical testing for commercial use and has the potential to be integrated into closed-loop AID systems. The current proposal will specifically address this by developing a “ketone-aware” AID system that receives dual input from the CKM/CGM sensor and subsequently optimizes glycemic control while minimizing ketosis. Our study aims are as follows: 1. We will refine and implement the Ketone-Aware Predictive Algorithm (kAPA), a ketone-aware algorithm with its roots in our recent SGLTi + AID crossover trial. Using archival data and CKM characteristics, we will model ketone elevation and measurement in our well-known simulation environment that is FDA-accepted for preclinical testing of AID systems. In parallel, we will create a kAPA model predictive AID controller and refine it in silico before implementing kAPA into our established DiAS prototyping platform. 2. We will demonstrate the feasibility and safety of kAPA in people with T1D by conducting a 36-hour supervised pilot study to demonstrate acceptable real-time ketosis control while taking sotagliflozin 200 mg; 3. We will demonstrate that kAPA improves glycemic control and minimizes ketosis by conducting a 12- week randomized, single-blind, placebo-controlled crossover clinical trial comparing kAPA + sotagliflozin to AID + placebo in people with T1D. Successful completion of this project will develop a proactive, ketone-aware AID system that can optimize glycemic control, minimize ketosis, and allow for safe administration of SGLTi medications in people with T1D.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $788,831 )
2026	2026	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 EMMET ST N	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	1/31/2026	NEW	$788,831
														Subtotal = $788,831

Grand Total All Awards = $788,831

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Development of a ketone-aware automated insulin delivery system to enable safe use of sodium-glucose cotransporter inhibitors in people with type 1 diabetes

Award Number: R01DK145849

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2026

PERIOD OF PERFORMANCE END DATE: 12/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer